Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
aggressive, Alliance, carcinoma, China, consulting, contest, contesting, deficiency, disaggregated, Ductal, endoxifen, estopped, feel, Indian, Israel, lesion, lump, month, Opponent, Opposition, Petition, Petitioner, PGR, post, progression, rarely, RECAST, resignation, screening, situ, stable, suitability, surveillance, Taiwan, Ukraine
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view